October 21, 2025
Pharmaceutical titan Purdue Pharma heralded Tuesday that its newest Chapter 11 plan has almost total support from voting creditors, saying the proposal could pave the way to creditors receiving more than $7 billion, after its well-publicized role in the opioid epidemic pushed the company into bankruptcy and the U.S. Supreme Court rejected its original plan.
October 17, 2025
Village Roadshow's third proposed sale will go before a judge. A bankruptcy court will consider confirming Heritage Coal's liquidation plan. And a CVS Health subsidiary will seek final approval of its bankruptcy financing.
September 22, 2025
A New Jersey bankruptcy judge gave Rite Aid the go-ahead to solicit Chapter 11 plan votes. A New York bankruptcy judge gave permission for Purdue Pharma to offer its chief executive a nearly $3 million incentive package. And a Delaware judge approved fiber network developer Tilson Technology Management Inc.'s asset sale to ITG Communications LLC.
September 17, 2025
A New York bankruptcy judge Wednesday approved a nearly $3 million incentive program for Purdue Pharma's chief executive after he agreed to reduce his total compensation by $500,000.
September 12, 2025
Purdue will ask a bankruptcy court to approve a retention incentive package for its CEO. Tilson Technology is scheduled for a hearing on its request for permission to complete a proposed asset sale. And the judge overseeing Steward Health Care's bankruptcy will consider whether to compel two hospital buyers to make payments and defend against accusations of contempt.
September 08, 2025
A New York judge authorized the Chapter 11 plan of the Roman Catholic Diocese of Rochester, Yellow Corp.'s newest bankruptcy plan disclosure statement won tentative approval, and Monster.com was given the go-ahead to begin collecting votes on a Chapter 11 plan. This is the week in bankruptcy.
September 04, 2025
Bankrupt pharmaceutical company Purdue Pharma LP received approval from a New York judge Thursday to pay more than $17.5 million in employee bonuses, mirroring the bonus structures of the last few years since the company commenced its Chapter 11 case.
August 29, 2025
A New York bankruptcy court will consider letting Purdue Pharma collaborate with a nonprofit on a cancer drug. A Delaware bankruptcy judge is slated to hear Monster.com's bid to begin soliciting votes on a Chapter 11 plan. And another bankruptcy judge in Delaware will weigh whether to grant interim approval for the combined plan and disclosure of Heritage Coal's owner.
August 20, 2025
Purdue Pharma LP asked a New York bankruptcy court to allow it to enter a clinical trial collaboration with a nonprofit, saying that doing so would allow Purdue to continue developing a potential treatment for a deadly brain cancer while restraining costs.
July 31, 2025
A New York bankruptcy judge Thursday gave an ad hoc governmental group permission to hire an administrator to handle claims in Purdue Pharma's $8 billion Chapter 11 plan, saying the administrator's services are needed.